Related Articles
Effective introduction of T cell costimulatory molecules into virus modified tumor cell vaccines by modification with bispecific antibodies
Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine
Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: Results from a phase Ⅰ clinical study